Theravance Biopharma
TBPH
TBPH
81 hedge funds and large institutions have $525M invested in Theravance Biopharma in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
2% less funds holding
Funds holding: 83 → 81 (-2)
Holders
81
Holding in Top 10
2
Calls
$1.11M
Puts
$920K
Top Buyers
| 1 | +$33.1M | |
| 2 | +$7.52M | |
| 3 | +$2.95M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.3M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$1.74M |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$2.29M | |
| 3 | -$1.29M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.23M |
| 5 |
Millennium Management
New York
|
-$1.03M |